Skip to main content

Table 1 The distribution of DM1 clinical features based on CTG repeats ranges

From: Clinical features and genetic spectrum of a multicenter Chinese cohort with myotonic dystrophy type 1

Feature

Total patients (n = 64)

CTG repeats 100–300 (n = 18)

CTG repeats 300–600 (n = 27)

CTG repeats 600–1900 (n = 19)

p

Age (mean (SD))

41 (12)

44 (15)

39 (11)

43 (9)

0.31

Male (%)

36 (56.2)

11 (61.1)

19 (70.4)

6 (31.6)

0.02

CTG repeat (mean (SD))

468 (139)

174 (44)

447 (81)

754 (105)

0.33

Onset age (%)

29 (13)

38 (11)

25 (12)

31 (13)

0.24

Muscle weakness

59 (92.2)

15 (83.3)

25 (92.6)

19 (100)

0.42

Myotonia (%)

55 (85.9)

16 (88.9)

25 (92.6)

14 (73.7)

0.18

Fatigue (%)

47 (73.4)

11 (61.1)

21 (77.8)

15 (78.9)

0.38

Heart palpitation (%)

20 (31.3)

8 (44.4)

9 (33.3)

3 (15.8)

0.16

Cataract surgery (%)

9 (14.1)

3 (16.7)

4 (14.8)

2 (10.5)

0.86

Tumor (%)

3 (4.7)

1 (5.6)

0 (0.0)

2 (10.5)

0.25

Diabetes (%)

11 (17.2)

5 (27.8)

5 (18.5)

1 (5.3)

0.19

Dyspnea (%)

15 (23.4)

4 (22.2)

6 (22.2)

5 (26.3)

0.94

Insomnia (%)

18 (28.1)

7 (38.9)

7 (25.9)

4 (21.1)

0.46

Daytime sleepiness (%)

45 (70.3)

13 (72.2)

23 (85.2)

9 (47.4)

0.02

FSS score (mean (SD))

42.02 (15.01)

42.44 (14.96)

43.04 (14.29)

44.42 (16.44)

0.62

ESS score (mean (SD))

10.50 (6.18)

11.50 (7.67)

10.85 (5.62)

9.05 (5.40)

0.46

  1. In general, patients with higher CTG repeats were more prone to exhibiting severe symptoms. FSS, Fatigue Severity Scale; ESS, Epworth Sleepiness Scale